APA (7th ed.) Citation

T, H., H, I., T, M., S, U., A, S., K, K., . . . K, K. (2021). Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs. British journal of haematology, 194(1), 101. https://doi.org/10.1111/bjh.17456

Chicago Style (17th ed.) Citation

T, Harada, et al. "Outcomes of Methotrexate-associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients Treated with Disease-modifying Anti-rheumatic Drugs." British Journal of Haematology 194, no. 1 (2021): 101. https://doi.org/10.1111/bjh.17456.

MLA (9th ed.) Citation

T, Harada, et al. "Outcomes of Methotrexate-associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients Treated with Disease-modifying Anti-rheumatic Drugs." British Journal of Haematology, vol. 194, no. 1, 2021, p. 101, https://doi.org/10.1111/bjh.17456.